Royal Bank of Canada
IMGN

Royal Bank of Canada’s Immunogen Inc IMGN Stock Holding History

Royal Bank of Canada’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-77,312
Closed -$2.29M – 7852
2023
Q4 		$2.29M Buy
77,312
+33,971
+78% +$676K ﹤0.01% 2960
2023
Q3 		$687K Buy
43,341
+21,450
+98% +$357K ﹤0.01% 3771
2023
Q2 		$413K Sell
21,891
-41,041
-65% -$485K ﹤0.01% 4098
2023
Q1 		$242K Sell
62,932
-50,076
-44% -$213K ﹤0.01% 4461
2022
Q4 		$560K Sell
113,008
-4,722
-4% -$25.6K ﹤0.01% 4011
2022
Q3 		$563K Buy
117,730
+16,125
+16% +$85K ﹤0.01% 3935
2022
Q2 		$457K Sell
101,605
-22,965
-18% -$99.8K ﹤0.01% 4170
2022
Q1 		$593K Sell
124,570
-31,631
-20% -$175K ﹤0.01% 4142
2021
Q4 		$1.16M Buy
156,201
+16,414
+12% +$102K ﹤0.01% 3657
2021
Q3 		$794K Buy
139,787
+7,038
+5% +$40.7K ﹤0.01% 3922
2021
Q2 		$874K Sell
132,749
-46,412
-26% -$324K ﹤0.01% 3777
2021
Q1 		$1.45M Buy
179,161
+57
+0% +$465 ﹤0.01% 3275
2020
Q4 		$1.16M Sell
179,104
-49,897
-22% -$291K ﹤0.01% 3374
2020
Q3 		$824K Buy
229,001
+30,808
+16% +$124K ﹤0.01% 3419
2020
Q2 		$911K Buy
198,193
+57,377
+41% +$244K ﹤0.01% 3254
2020
Q1 		$480K Buy
140,816
+332
+0.2% +$1.45K ﹤0.01% 3652
2019
Q4 		$717K Sell
140,484
-5,403
-4% -$18.3K ﹤0.01% 3713
2019
Q3 		$353K Buy
145,887
+4,131
+3% +$11K ﹤0.01% 4057
2019
Q2 		$308K Buy
141,756
+16,524
+13% +$39.1K ﹤0.01% 4190
2019
Q1 		$339K Buy
125,232
+2,785
+2% +$12.1K ﹤0.01% 4015
2018
Q4 		$587K Sell
122,447
-7,696
-6% -$46.7K ﹤0.01% 3601
2018
Q3 		$1.23M Buy
130,143
+13,759
+12% +$132K ﹤0.01% 3200
2018
Q2 		$1.13M Sell
116,384
-14,004
-11% -$148K ﹤0.01% 3133
2018
Q1 		$1.37M Sell
130,388
-92,750
-42% -$916K ﹤0.01% 2947
2017
Q4 		$1.43M Buy
223,138
+57,200
+34% +$353K ﹤0.01% 2981
2017
Q3 		$1.27M Buy
165,938
+11,506
+7% +$76.5K ﹤0.01% 3028
2017
Q2 		$1.1M Buy
154,432
+137,061
+789% +$627K ﹤0.01% 3045
2017
Q1 		$68K Sell
17,371
-2,253
-11% -$6.58K ﹤0.01% 4990
2016
Q4 		$39K Buy
19,624
+2,848
+17% +$5.72K ﹤0.01% 5410
2016
Q3 		$45K Sell
16,776
-2,984
-15% -$8.68K ﹤0.01% 5211
2016
Q2 		$62K Buy
19,760
+102
+0.5% +$640 ﹤0.01% 5022
2016
Q1 		$167K Sell
19,658
-8,079
-29% -$68.4K ﹤0.01% 4476
2015
Q4 		$376K Buy
27,737
+1,021
+4% +$12.6K ﹤0.01% 4033
2015
Q3 		$256K Buy
26,716
+3,131
+13% +$45.8K ﹤0.01% 4105
2015
Q2 		$339K Buy
23,585
+249
+1% +$2.73K ﹤0.01% 3948
2015
Q1 		$209K Sell
23,336
-5,134
-18% -$37.2K ﹤0.01% 4206
2014
Q4 		$174K Buy
28,470
+10,481
+58% +$95.8K ﹤0.01% 4436
2014
Q3 		$190K Sell
17,989
-16,455
-48% -$186K ﹤0.01% 4222
2014
Q2 		$408K Buy
34,444
+7,040
+26% +$88.4K ﹤0.01% 3614
2014
Q1 		$409K Buy
27,404
+4,855
+22% +$76.5K ﹤0.01% 3521
2013
Q4 		$331K Sell
22,549
-6,109
-21% -$93.9K ﹤0.01% 3739
2013
Q3 		$487K Sell
28,658
-3,483
-11% -$61.2K ﹤0.01% 3391
2013
Q2 		$532K Buy
+32,141
New +$521K ﹤0.01% 3105

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Royal Bank of Canada's IMGN Position: Q1 2024 in Review

Royal Bank of Canada sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 77,312 shares — an estimated $2.29M sold.

Royal Bank of Canada first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $2.29M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Royal Bank of Canada reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 77,312 Immunogen Inc shares in Q1 2024, an estimated $2.29M.
  • Royal Bank of Canada first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Royal Bank of Canada's Immunogen Inc position peaked at $2.29M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.